Pancreas Disorder and Islet Transplantation
Stem cell-derived pancreatic islet transplantation is a β-cell replacement therapy which involves transplantation of isolated islets from donor pancreas to receiver, for the treatment of insulin-deficient diabetes. Once they are transplanted, the islets start producing insulin and actively regulate blood glucose levels. It was observed that 70% of patients who received an islet cell transplant no longer needs insulin after one year and may not need it in the future. Some of the benefits of Islet Transplantation are
- Improved blood glucose levels
- Less need or no need for insulin injections to manage diabetes
- Fewer or no episodes of severe hypoglycaemia
Related Conference of Pancreas Disorder and Islet Transplantation
September 23-24, 2026
24th Global Conference on Diabetes, Endocrinology and Primary Healthcare
Paris, France
September 28-29, 2026
25th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders
Berlin, Germany
November 23-24, 2026
35th International Conference on Clinical Diabetes, Diabetic Medication & Treatment
Amsterdam, Netherlands